Compile Data Set for Download or QSAR
Found 208 Enz. Inhib. hit(s) with all data for entry = 3071
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50383379(CHEMBL2030552 | CHEMBL2069958 | US9518026, Example...)copy SMILEScopy InChI
Affinity DataIC50: 1nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50389704(CHEMBL2070081 | US10544104, Compound 150 | US95180...)copy SMILEScopy InChI
Affinity DataIC50: 1nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50446179(CHEMBL3109011 | US9518026, Example 39 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 1nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50446179(CHEMBL3109011 | US9518026, Example 39 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 1nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50446181(CHEMBL3108912 | US9518026, Example 1 | US9956214, ...)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50446180(CHEMBL3108998 | US9518026, Example 25 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50446180(CHEMBL3108998 | US9518026, Example 25 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50446179(CHEMBL3109011 | US9518026, Example 39 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50446179(CHEMBL3109011 | US9518026, Example 39 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50148641(CHEMBL3770649 | US9518026, Example 49 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50148652(CHEMBL3770802 | US9518026, Example 57 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50148722(CHEMBL3770980 | US9518026, Example 59 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50148650(CHEMBL3770142 | US9518026, Example 103 | US9956214...)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50383379(CHEMBL2030552 | CHEMBL2069958 | US9518026, Example...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50389704(CHEMBL2070081 | US10544104, Compound 150 | US95180...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50148636(CHEMBL3769685 | US9518026, Example 45 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50148649(CHEMBL3771306 | US9518026, Example 55 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50148651(CHEMBL3771134 | US9518026, Example 56 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50148728(CHEMBL3770425 | US9518026, Example 65 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50148731(CHEMBL3771242 | US9518026, Example 68 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50148750(CHEMBL3770299 | US9518026, Example 71 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50148751(CHEMBL3769798 | US9518026, Example 72 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM286282(US9518026, Example 75 | US9956214, Compound 1656)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50200560(CHEMBL3922900 | US9518026, Example 92 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50200561(CHEMBL3973192 | US9518026, Example 97 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50446181(CHEMBL3108912 | US9518026, Example 1 | US9956214, ...)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50446178(CHEMBL3108913 | US9518026, Example 3 | US9956214, ...)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50446178(CHEMBL3108913 | US9518026, Example 3 | US9956214, ...)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50446177(CHEMBL3108991 | US9518026, Example 18 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50148638(CHEMBL3769623 | US9518026, Example 46 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50148652(CHEMBL3770802 | US9518026, Example 57 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50148751(CHEMBL3769798 | US9518026, Example 72 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM286283(US9518026, Example 76 | US9956214, Compound 1658)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50200563(CHEMBL3956316 | US9518026, Example 99 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50446176(CHEMBL3108996 | US9518026, Example 23 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50148632(CHEMBL3770409 | US9518026, Example 40 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50148634(CHEMBL3769900 | US9518026, Example 43 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50148635(CHEMBL3769940 | US9518026, Example 44 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50148639(CHEMBL3770760 | US9518026, Example 47 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50148647(CHEMBL3769570 | US9518026, Example 53 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50148648(CHEMBL3770743 | US9518026, Example 54 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50148728(CHEMBL3770425 | US9518026, Example 65 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50148730(CHEMBL3770546 | US9518026, Example 67 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50148731(CHEMBL3771242 | US9518026, Example 68 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50148749(CHEMBL3770313 | US9518026, Example 70 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50148752(CHEMBL3769990 | US9518026, Example 73 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM286281(US9518026, Example 74 | US9956214, Compound 1657)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM286287(US9518026, Example 80 | US9956214, Compound 1644)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50200562(CHEMBL3985876 | US9518026, Example 81 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
Boehringer Ingelheim (Canada) Ltd.

LigandPNGBDBM50200559(CHEMBL3922004 | US9518026, Example 94 | US9956214,...)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q23J3G91US Patent
Displayed 1 to 50 (of 208 total ) | Next | Last >>
Jump to: